{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:07:12Z","timestamp":1793153232431,"version":"4.5.0"},"reference-count":40,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/08765\u20109"],"award-info":[{"award-number":["2014\/08765\u20109"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2011\/21818\u20106"],"award-info":[{"award-number":["2011\/21818\u20106"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["140241\/2012\u20104"],"award-info":[{"award-number":["140241\/2012\u20104"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["130405\/2011\u20106"],"award-info":[{"award-number":["130405\/2011\u20106"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To investigate whether mood disorders (\n                      <jats:styled-content style=\"fixed-case\">MD<\/jats:styled-content>\n                      ) and anxiety disorders (\n                      <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>\n                      ) are associated with seizure control in patients with mesial temporal lobe epilepsy (\n                      <jats:styled-content style=\"fixed-case\">MTLE<\/jats:styled-content>\n                      ). We compared patients without any current psychiatric disorder, patients with current\n                      <jats:styled-content style=\"fixed-case\">MD<\/jats:styled-content>\n                      and\/or\n                      <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>\n                      , patients with subsyndromic depression episodes (\n                      <jats:styled-content style=\"fixed-case\">SSDE<\/jats:styled-content>\n                      ) and anxiety episodes (\n                      <jats:styled-content style=\"fixed-case\">SSAE<\/jats:styled-content>\n                      ), and patients with family psychiatric history.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In a cross\u2010sectional study, we included 144 consecutive patients with\n                      <jats:styled-content style=\"fixed-case\">MTLE<\/jats:styled-content>\n                      (82 pharmacoresistant and 62 treatment\u2010responsive patients). Every patient underwent a psychiatric evaluation including the Structured Clinical Interview for\n                      <jats:styled-content style=\"fixed-case\">DSM<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content>\n                      (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) Axis I (\n                      <jats:styled-content style=\"fixed-case\">SCID<\/jats:styled-content>\n                      \u2010I), Beck Depression Inventory (\n                      <jats:styled-content style=\"fixed-case\">BDI<\/jats:styled-content>\n                      ), Beck Anxiety Inventory (\n                      <jats:styled-content style=\"fixed-case\">BAI<\/jats:styled-content>\n                      ), Neurological Disorders Depression Inventory for Epilepsy (\n                      <jats:styled-content style=\"fixed-case\">NDDI<\/jats:styled-content>\n                      \u2010E), and Interictal Dysphoric Disorder Inventory (\n                      <jats:styled-content style=\"fixed-case\">IDDI<\/jats:styled-content>\n                      ). Patients were divided into four groups: PsychNeg (G1, n = 61), current\n                      <jats:styled-content style=\"fixed-case\">SSDE<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">SSAE<\/jats:styled-content>\n                      (G2, n = 26), Current\n                      <jats:styled-content style=\"fixed-case\">MD<\/jats:styled-content>\n                      or\n                      <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>\n                      (G3, n = 25), and current mixed\n                      <jats:styled-content style=\"fixed-case\">MD<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>\n                      (G4, n = 32).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among patients with pharmacoresistant\n                      <jats:styled-content style=\"fixed-case\">MTLE<\/jats:styled-content>\n                      , 68.3% (56\/82) experienced symptoms of depression and\/or anxiety (G2, G3, and G4) (\n                      <jats:styled-content style=\"fixed-case\">odds ratio [OR]<\/jats:styled-content>\n                      2.8, 95%\n                      <jats:styled-content style=\"fixed-case\">confidence interval [CI]<\/jats:styled-content>\n                      1.41\u20135.53, p &lt; 0.01). Patients with mixed\n                      <jats:styled-content style=\"fixed-case\">MD<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>\n                      (G4, n = 24\/32) were more likely to have pharmacoresistant\n                      <jats:styled-content style=\"fixed-case\">MTLE<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      4.04, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.57\u201310.42, p &lt; 0.01) than psychiatric asymptomatic patients (G1, n = 26\/61), and their seizure frequency was significantly higher (p &lt; 0.01). Positive family psychiatric history was more frequent in pharmacoresistant patients (n = 27\/82,\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      2.28, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.02\u20135.05, p = 0.04). Finally, 31.6% of patients with\n                      <jats:styled-content style=\"fixed-case\">MD<\/jats:styled-content>\n                      and or\n                      <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>\n                      were not receiving psychiatric treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>\n                      Identification of comorbid\n                      <jats:styled-content style=\"fixed-case\">MD<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>\n                      and of family psychiatric history is of the essence in patients with\n                      <jats:styled-content style=\"fixed-case\">MTLE,<\/jats:styled-content>\n                      as they appear to be associated with worse seizure control.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/epi.13781","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T11:42:37Z","timestamp":1495798957000},"page":"1268-1276","source":"Crossref","is-referenced-by-count":106,"title":["Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE"],"prefix":"10.1111","volume":"58","author":[{"given":"Mateus H.","family":"Nogueira","sequence":"first","affiliation":[{"name":"Laboratory of Neuroimaging University of Campinas UNICAMP Campinas SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa L.","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroimaging University of Campinas UNICAMP Campinas SP Brazil"},{"name":"Department of Neurology University of Campinas UNICAMP Campinas SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Coan","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroimaging University of Campinas UNICAMP Campinas SP Brazil"},{"name":"Department of Neurology University of Campinas UNICAMP Campinas SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres M.","family":"Kanner","sequence":"additional","affiliation":[{"name":"Department of Neurology Miller School of Medicine University of Miami Miami Florida U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-9568","authenticated-orcid":false,"given":"Fernando","family":"Cendes","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroimaging University of Campinas UNICAMP Campinas SP Brazil"},{"name":"Department of Neurology University of Campinas UNICAMP Campinas SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2010.07.004"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1676-26492007000100004"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2004.00324.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2011000300015"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.17.2.172"},{"key":"e_1_2_9_7_1","volume-title":"Diagnostic and Statistical Manual for Mental Disorders (DSM\u2010IV)","author":"American Psychiatric Association","year":"2000"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02582.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03488.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.5698\/1535-7597-14.6.323"},{"key":"e_1_2_9_11_1","first-page":"360","volume-title":"Neurobiology of mental illness","author":"Lohoff FW","year":"2010"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02522.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02397.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462001000300008"},{"key":"e_1_2_9_16_1","first-page":"453","article-title":"Validation of a Portuguese version of the Beck Depression Inventory and the State\u2010Trait Anxiety Inventory in Brazilian subjects","volume":"29","author":"Gorenstein C","year":"1996","journal-title":"Braz J Med Biol Res"},{"key":"e_1_2_9_17_1","volume-title":"Manual of Beck scales in Portuguese","author":"Cunha JA","year":"2001"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2010.07.013"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1676-26492010000400007"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2007.06.003"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2013.07.041"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f25b16"},{"issue":"46","key":"e_1_2_9_23_1","first-page":"41","article-title":"Differential effect of mood and anxiety disorders on the quality of life and perception of adverse events to antiepileptic drugs in patients with epilepsy. In: abstracts from the 2007 Annual Meeting of the American Epilepsy Society","volume":"48","author":"Kanner AM","year":"2007","journal-title":"Epilepsia"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2003.05402.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23679"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23601"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20685"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2007.05.011"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.03.017"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301234"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02355.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(94)90163-5"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-5050(03)00182-3"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.06.038"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2016.02.014"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000278112.48285.84"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1535-7511.2006.00125.x"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-000-0035-9"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12603"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.02.034"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fepi.13781","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.13781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:23:20Z","timestamp":1695543800000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/epi.13781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1111\/epi.13781"],"URL":"https:\/\/doi.org\/10.1111\/epi.13781","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,26]]}}}